XML 33 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
3 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Operating Activities:    
Net income (loss) $ 313,946 $ (355,367)
Less: Net income from discontinued operations (Note 16)   81,520
Income (loss) from continuing operations 313,946 (436,887)
Adjustments to reconcile net income to net cash provided by operating activities of continuing operations:    
Depreciation and amortization 22,776 48,304
Provision for doubtful accounts   56,000
Warranty provision 64,310 (14,947)
Inventory obsolescence 162,602 (38,743)
Share-based compensation 139,286 113,303
Loss on impairment of patents 10,616 1,748
Changes in operating assets and liabilities:    
Restricted cash   (3,031,250)
Accounts receivable 2,358,304 2,204,760
Inventories (373,174) (2,968,193)
Prepaid expenses and other 107,450 (10,978)
Prepaid expenses - noncurrent 15,515  
Accounts payable (443,881) 1,268,445
Warranty settlements (13,095) (15,838)
Accrued liabilities (2,383,183) 822,846
Net cash used in operating activities of continuing operations (18,528) (2,001,430)
Net cash used in (provided by) operating activities of discontinued operations (Note 16) (3,013) 100,718
Net cash used in operating activities (21,541) (1,900,712)
Investing Activities:    
Purchase of equipment (3,617) (6,958)
Patent costs paid (227) (55)
Net cash used in investing activities (3,844) (7,013)
Financing Activities:    
Proceeds from exercise of stock options   94,841
Net cash provided by financing activities   94,841
Net decrease in cash and cash equivalents (25,385) (1,812,884)
Cash and cash equivalents, beginning of period 13,870,762 5,421,167
Cash and cash equivalents, end of period 13,845,377 3,608,283
Supplemental Disclosure of Cash Flow Information    
Cash paid for taxes $ 50,000 $ 108,000